Canon Medical Systems USA has earned clearance from the Food and Drug Administration for expanded use of its artificial intelligence software to aid in CT image acquisition.
With the FDA’s blessing, the Tustin, California, company can now offer its Deep Learning Spectral CT tool for cardiovascular applications. Healthcare providers can use this AI aid to acquire whole-heart spectral images in “one beat,” Canon announced Monday.
“By integrating AI into spectral imaging, Canon Medical is bringing innovative technology to the market that can make an immediate impact for clinicians, empowering them to make definitive diagnoses,” Erin Angel, managing director of Canon’s CT business unit, said in a statement. “With Deep Learning Spectral CT, we have leveraged the power of AI to overcome several of the barriers that are otherwise associated with dual energy and spectral imaging,” she added.
Marty Stempniak has covered healthcare since 2012, with his byline appearing in the American Hospital Association's member magazine, Modern Healthcare and McKnight's. Prior to that, he wrote about village government and local business for his hometown newspaper in Oak Park, Illinois. He won a Peter Lisagor and Gold EXCEL awards in 2017 for his coverage of the opioid epidemic.